Maybe that’s why they pushed through the NZ Enliven sign up news?
Which means there is that strongly hinted at UK announcement that might also arrive shortly?
(Ie if directors want to sell they are surely better off doing so after good news rather than before)
And, as far as NZ goes, I was trying to find the comment (from Technow?) on the largest RAC provider in NZ being interested. (Seeing as I don’t think Enliven’s five homes and 300 residents qualify it for that description.)
I still haven’t found it, but happily came across @Double Down ’s excellent summation on 25/10/19 of his time with David Allsopp ...(41075263)
Including;
.. “There are only six major players in NZ aged care, the largest is significantly larger than the largest player in Aus. In that regard the approach to NZ is far more simple and as the trials turn to contracts there they will update us. It's not a matter of if there, it's when.
So if there was talk of the largest NZ provider also being interested/running trials maybe it will now promptly follow Enliven’s lead so as not to appear to offer an inferior range of services?
Another comment jumped out at me on the re-read as well ( thank you again Double Down!)
... “the cost of PainChek is a serious consideration. They are currently collecting data on savings from removing the over prescribing drugs in order to make a financial argument for using PainChek.”
@GCInvestor it would be interesting to find out how that data collection is going? Could you add this request to your next email please?
